Fundamentals Overview
AbbVie Inc. is near the high of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Intrinsic value (DCF)
-43.4% downside vs price
Profitability
Risk (Beta)
0.28 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: B- · 3M vs S&P 500: +8.2% · 3M vs Healthcare sector: +11.3%
Pressures (Sell):
DCF 43.4% downside vs price
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B-. Recent institutional grades: mixed. Current institutional positions: Buy: 9, Neutral: 3, Outperform: 5, Overweight: 12, Peer Perform: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $138.28; current price is $244.22. That’s a -43.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 119.06 |
| DCF value (model) | $138.28 (-43.4% vs price) |
| PEG (TTM) | N/A |
| P/B (TTM) | 15.75 |
| P/S (TTM) | 6.87 |
| P/FCF (TTM) | 20.68 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 0.8 |
| Quick Ratio (TTM) | 0.68 |
| Cash Ratio (TTM) | 0.22 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 5.79% |
| Gross margin (TTM) | 70.68% |
| Operating margin (TTM) | 27.6% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for ABBV.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| BMO Capital | maintain | Outperform | Outperform | 2026-07-13 |
| UBS | maintain | Neutral | Neutral | 2026-07-13 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-07-10 |
| RBC Capital | maintain | Outperform | Outperform | 2026-07-10 |
| B of A Securities | maintain | Buy | Buy | 2026-07-10 |
| Guggenheim | maintain | Buy | Buy | 2026-07-09 |
| JP Morgan | maintain | Overweight | Overweight | 2026-07-09 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2026-07-06 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-06-23 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-06-23 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-05-15 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-05-14 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-05-04 |
| Guggenheim | maintain | Buy | Buy | 2026-05-01 |
| Morgan Stanley | maintain | Overweight | Overweight | 2026-04-30 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2026-04-30 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-04-30 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-04-23 |
| Guggenheim | maintain | Buy | Buy | 2026-04-10 |
| Cantor Fitzgerald | maintain | Overweight | Overweight | 2026-04-08 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-18 |
| Freedom Broker | maintain | Buy | Buy | 2026-02-17 |
| UBS | maintain | Neutral | Neutral | 2026-02-05 |
| Morgan Stanley | maintain | Overweight | Overweight | 2026-02-05 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-02-05 |
| Citigroup | maintain | Neutral | Neutral | 2026-01-27 |
| Wolfe Research | downgrade | Outperform | Peer Perform | 2026-01-08 |
| Morgan Stanley | maintain | Overweight | Overweight | 2025-12-12 |
| HSBC | upgrade | Hold | Buy | 2025-12-10 |
| Freedom Broker | maintain | Buy | Buy | 2025-11-12 |